Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues

UnitedHealth says wide swath of patient files may have been taken in Change cyberattack

Cyberattack costs hit UnitedHealth in 1Q that still turns out better than expected

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

J&J to pump another $13B into its MedTech business with Shockwave deal

Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics

Insurer delays and denials hamper patients seeking at-home breathing machines

CVS and Walgreens plan to start dispensing abortion pill mifepristone soon

Weight loss, diabetes drugs propel Eli Lilly to largely better-than-expected forecast for 2024

Insider Q&A: Look for telemedicine to play a growing role in your regular care

Biogen will stop selling its controversial Alzheimer's drug Aduhelm

Pfizer earnings beat Wall Street expectations as other products make up for slumping COVID-19 drugs

Humana warns that rising care costs will persist through 2024, surprises Wall Street with forecast

Late-year medical costs spike forces Humana to scale back profit expectations for 2023

UnitedHealth shares tumble after health care giant reports soaring medical costs in 4Q

Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugs

Drugstore chain Walgreens cuts quarterly dividend to get more cash to grow its business

Subscription-based care moves beyond peddling birth control and helping with hair loss

Rite Aid banned from facial recognition tech use for 5 years after faulty theft targeting in stores

Switch from selling COVID-19 drugs on market rather than to governments continues to sting at Pfizer

More stories